Sa1765 SYMPTOMATIC REMISSION AND IUS IMPROVEMENTS IN A MULTINATIONAL REAL-WORLD COHORT OF UC PATIENTS TREATED WITH UPADACITINIB - FIRST RESULTS FROM THE IBD-DACH STUDY EUROPE

Gastroenterology(2024)

Cited 0|Views6
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined